MPS Pharmaa Limited

Equities

ADVIKLA

INE537C01019

Market Closed - Bombay S.E. 06:00:55 2024-05-13 am EDT 5-day change 1st Jan Change
3.33 INR +4.72% Intraday chart for MPS Pharmaa Limited +4.72% +19.35%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
MPS Pharmaa Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
MPS Pharmaa Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
MPS Pharmaa Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
MPS Pharmaa Limited Announces Resignation of Manoj Kumar Jain from the Position of the Independent Director of the Company with Immediate Effect CI
MPS Pharmaa Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
MPS Pharmaa Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Advik Laboratories Changes Company Name MT
ADVIK LABORATORIES LIMITED has Changed its Name to MPS PHARMAA LIMITED CI
Advik Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Pataliputra International Ltd acquired a 17.51% stake in Advik Laboratories Limited from Vikas Lifecare Limited for INR 6.09 million. CI
Advik Laboratories Changes Name MT
Advik Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Advik Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Advik Laboratories Limited announced that it expects to receive INR 62.5 million in funding from Neelabh Spinning Mills Pvt. Ltd., Omkam Securities Private Limited, Dhiru Builders and Promoters Private Limited and other investors CI
Advik Laboratories Narrows Net Loss in Fiscal Q3; Shares Jump 5% MT
Advik Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Advik Laboratories : Fully Pays Outstanding Loan from Indian Overseas Bank MT
Advik Laboratories Limited Announces Settlement of Entire Outstanding Loan with Indian Overseas Bank CI
Advik Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Vikas Lifecare : to Acquire Remaining Stake in Indian Pharmaceutical Company MT
Vikas Multicorp Limited completed the acquisition of an unknown stake in Advik Laboratories Limited from Advik's promoters. CI
Vikas Multicorp Limited agreed to acquire an unknown stake in Advik Laboratories Limited from Advik's promoters. CI
Advik Laboratories Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Advik Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2020 CI
Advik Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020 CI
  1. Stock Market
  2. Equities
  3. ADVIKLA Stock
  4. News MPS Pharmaa Limited
  5. Advik Laboratories : Fully Pays Outstanding Loan from Indian Overseas Bank
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW